920 related articles for article (PubMed ID: 27111516)
1. Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus.
Wu Y; Chen Y; Yang X; Chen L; Yang Y
Int Immunopharmacol; 2016 Jul; 36():94-99. PubMed ID: 27111516
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients.
Qin B; Ma N; Tang Q; Wei T; Yang M; Fu H; Hu Z; Liang Y; Yang Z; Zhong R
Mod Rheumatol; 2016; 26(3):372-6. PubMed ID: 26403379
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil to lymphocyte and platelet to lymphocyte ratios in systemic lupus erythematosus: Relation with disease activity and lupus nephritis.
Soliman WM; Sherif NM; Ghanima IM; El-Badawy MA
Reumatol Clin (Engl Ed); 2020; 16(4):255-261. PubMed ID: 30166230
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with systemic lupus erythematosus and their correlation with activity: A meta-analysis.
Ma L; Zeng A; Chen B; Chen Y; Zhou R
Int Immunopharmacol; 2019 Nov; 76():105949. PubMed ID: 31634817
[TBL] [Abstract][Full Text] [Related]
5. Two new inflammatory markers associated with Disease Activity Score-28 in patients with rheumatoid arthritis: neutrophil-lymphocyte ratio and platelet-lymphocyte ratio.
Uslu AU; Küçük A; Şahin A; Ugan Y; Yılmaz R; Güngör T; Bağcacı S; Küçükşen S
Int J Rheum Dis; 2015 Sep; 18(7):731-5. PubMed ID: 25900081
[TBL] [Abstract][Full Text] [Related]
6. Platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) are associated with chronic hepatitis B virus (HBV) infection.
Zhao Z; Liu J; Wang J; Xie T; Zhang Q; Feng S; Deng H; Zhong B
Int Immunopharmacol; 2017 Oct; 51():1-8. PubMed ID: 28759808
[TBL] [Abstract][Full Text] [Related]
7. Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio associated with disease activity in patients with Takayasu's arteritis: a case-control study.
Pan L; Du J; Li T; Liao H
BMJ Open; 2017 May; 7(4):e014451. PubMed ID: 28473512
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of neutrophil-to-lymphocyte ratio as a biomarker for diagnosing infections in patients with systemic lupus erythematosus.
Kim HA; Jung JY; Suh CH
Clin Rheumatol; 2017 Nov; 36(11):2479-2485. PubMed ID: 28840341
[TBL] [Abstract][Full Text] [Related]
9. Could systemic immune inflammation index be a new parameter for diagnosis and disease activity assessment in systemic lupus erythematosus?
Ozdemir A; Baran E; Kutu M; Celik S; Yılmaz M
Int Urol Nephrol; 2023 Jan; 55(1):211-216. PubMed ID: 35918626
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are 2 new inflammatory markers associated with pulmonary involvement and disease activity in patients with dermatomyositis.
Yang W; Wang X; Zhang W; Ying H; Xu Y; Zhang J; Min Q; Chen J
Clin Chim Acta; 2017 Feb; 465():11-16. PubMed ID: 27965019
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-to-C3 ratio and neutrophil-to-lymphocyte ratio were associated with disease activity in patients with systemic lupus erythematosus.
Yu J; Zeng T; Wu Y; Tian Y; Tan L; Duan X; Wu Q; Li H; Yu L
J Clin Lab Anal; 2019 Jan; 33(1):e22633. PubMed ID: 30129188
[TBL] [Abstract][Full Text] [Related]
12. [Association between platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio with disease activity in Takayasu arteritis patients].
Li ZQ; Zheng ZH; Du WL; Pang LX; Li Y; Wu ZB; Zhu P
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Sep; 46(9):713-718. PubMed ID: 30293378
[No Abstract] [Full Text] [Related]
13. Neutrophil-to-lymphocyte ratios and platelet-to-lymphocyte ratios in juvenile systemic lupus erythematosus: correlation with disease manifestations.
Li W; Liu S; Chen C; Han Y
Ann Palliat Med; 2021 Sep; 10(9):9406-9414. PubMed ID: 34628866
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD.
Yao C; Liu X; Tang Z
Int J Chron Obstruct Pulmon Dis; 2017; 12():2285-2290. PubMed ID: 28814856
[TBL] [Abstract][Full Text] [Related]
15. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
Deng M; Ma X; Liang X; Zhu C; Wang M
Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio reflect disease activity and flares in patients with systemic lupus erythematosus - A prospective study.
Cho J; Liang S; Lim SHH; Lateef A; Tay SH; Mak A
Joint Bone Spine; 2022 Jul; 89(4):105342. PubMed ID: 35032639
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer.
Cho KM; Park H; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
Oncotarget; 2017 Jan; 8(2):2329-2341. PubMed ID: 27911876
[TBL] [Abstract][Full Text] [Related]
18. Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer.
Huang Z; Liu Y; Yang C; Li X; Pan C; Rao J; Li N; Liao W; Lin L
BMC Cancer; 2018 May; 18(1):515. PubMed ID: 29720123
[TBL] [Abstract][Full Text] [Related]
19. Platelet-to-lymphocyte ratio as a biomarker of systemic inflammation in systemic lupus erythematosus: A meta-analysis and systematic review.
Lee YH; Song GG
PLoS One; 2024; 19(5):e0303665. PubMed ID: 38753735
[TBL] [Abstract][Full Text] [Related]
20. SIGNIFICANCE OF NEUTROPHIL-LYMPHOCYTE RATIO AND PLATELET-LYMPHOCYTE RATIO AS PROGNOSTIC MARKERS OF DISEASE SEVERITY IN SYSTEMIC LUPUS ERYTHEMATOSUS.
Babu N; Nilofar F; Palanisamy S; Gnanadeepan T; Kumar M
Georgian Med News; 2024 Feb; (347):108-112. PubMed ID: 38609124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
